Literature DB >> 22433764

Improving the measurement of QALYs in dementia: developing patient- and carer-reported health state classification systems using Rasch analysis.

Brendan Mulhern1, Sarah C Smith, Donna Rowen, John E Brazier, Martin Knapp, Donna L Lamping, Vanessa Loftus, Tracey A Young, Robert J Howard, Sube Banerjee.   

Abstract

OBJECTIVES: Cost-utility analysis is increasingly used to inform resource allocation. This requires a means of valuing health states before and after intervention. Although generic measures are typically used to generate values, these do not perform well with people with dementia. We report the development of a health state classification system amenable to valuation for use in studies of dementia, derived from the DEMQOL system, measure of health-related quality of life in dementia by patient self-report (DEMQOL) and carer proxy-report (DEMQOL-Proxy).
METHODS: Factor analysis was used to determine the dimensional structure of DEMQOL and DEMQOL-Proxy. Rasch analysis was subsequently used to investigate item performance across factors in terms of item-level ordering, functioning across subgroups, model fit, and severity-range coverage. This enabled the selection of one item from each factor for the classification system. A sample of people with a diagnosis of mild/moderate dementia (n = 644) and a sample of carers of those with mild/moderate dementia (n = 683) were used.
RESULTS: Factor analysis found different five-factor solutions for DEMQOL and DEMQOL-Proxy. Following item reduction and selection by using Rasch analysis, a five-dimension classification for DEMQOL and a four-dimension classification for DEMQOL-Proxy were developed. Each item contained four health state levels.
CONCLUSION: Combining Rasch and classical psychometric analysis is a valid method of selecting items for dementia health state classifications from both the patient and carer perspectives. The next stage is to obtain preference weights so that the measure can be used in the economic evaluation of treatment, care, and support arrangements for dementia. Copyright Â
© 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22433764     DOI: 10.1016/j.jval.2011.09.006

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  14 in total

Review 1.  The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.

Authors:  Donna Rowen; John Brazier; Roberta Ara; Ismail Azzabi Zouraq
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

2.  Comparison of general population, patient, and carer utility values for dementia health states.

Authors:  Donna Rowen; Brendan Mulhern; Sube Banerjee; Rhian Tait; Caroline Watchurst; Sarah C Smith; Tracey A Young; Martin Knapp; John E Brazier
Journal:  Med Decis Making       Date:  2014-11-10       Impact factor: 2.583

3.  Monetary costs of agitation in older adults with Alzheimer's disease in the UK: prospective cohort study.

Authors:  Stephen Morris; Nishma Patel; Gianluca Baio; Lynsey Kelly; Elanor Lewis-Holmes; Rumana Z Omar; Cornelius Katona; Claudia Cooper; Gill Livingston
Journal:  BMJ Open       Date:  2015-03-13       Impact factor: 2.692

4.  Economic Evaluation of a General Hospital Unit for Older People with Delirium and Dementia (TEAM Randomised Controlled Trial).

Authors:  Lukasz Tanajewski; Matthew Franklin; Georgios Gkountouras; Vladislav Berdunov; Rowan H Harwood; Sarah E Goldberg; Lucy E Bradshaw; John R F Gladman; Rachel A Elliott
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

5.  Developing a dementia-specific health state classification system for a new preference-based instrument AD-5D.

Authors:  Kim-Huong Nguyen; Brendan Mulhern; Sanjeewa Kularatna; Joshua Byrnes; Wendy Moyle; Tracy Comans
Journal:  Health Qual Life Outcomes       Date:  2017-01-25       Impact factor: 3.186

6.  Developing a dementia-specific preference--based quality of life measure (AD-5D) in Australia: a valuation study protocol.

Authors:  Tracy A Comans; Kim-Huong Nguyen; Brendan Mulhern; Megan Corlis; Li Li; Alyssa Welch; Susan E Kurrle; Donna Rowen; Wendy Moyle; Sanjeewa Kularatna; Julie Ratcliffe
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

7.  Development of a patient reported outcome measures for measuring the impact of visual impairment following stroke.

Authors:  Lauren R Hepworth; Fiona J Rowe; Girvan Burnside
Journal:  BMC Health Serv Res       Date:  2019-05-31       Impact factor: 2.655

8.  Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module.

Authors:  Jesús Cuervo; Nacho Castejón; Kristin M Khalaf; Catherine Waweru; Denise Globe; Donald L Patrick
Journal:  Health Qual Life Outcomes       Date:  2014-10-08       Impact factor: 3.186

9.  Can the general public use vignettes to discriminate between Alzheimer's disease health states?

Authors:  Mark Oremus; Feng Xie; Eleanor Pullenayegum; Kathryn Gaebel
Journal:  BMC Geriatr       Date:  2016-02-03       Impact factor: 3.921

10.  DREAMS-START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives) for people with dementia and sleep disturbances: a single-blind feasibility and acceptability randomized controlled trial.

Authors:  Gill Livingston; Julie A Barber; Kirsi M Kinnunen; Lucy Webster; Simon D Kyle; Claudia Cooper; Colin A Espie; Brendan Hallam; Rossana Horsley; James Pickett; Penny Rapaport
Journal:  Int Psychogeriatr       Date:  2018-09-17       Impact factor: 3.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.